A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc.
Nimbus Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
IFOM ETS - The AIRC Institute of Molecular Oncology
Accent Therapeutics
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
GERCOR - Multidisciplinary Oncology Cooperative Group
University of Pittsburgh
Marengo Therapeutics, Inc.
GERCOR - Multidisciplinary Oncology Cooperative Group
Gruppo Oncologico del Nord-Ovest
M.D. Anderson Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Blokhin's Russian Cancer Research Center
UNICANCER
Assistance Publique - Hôpitaux de Paris
Fate Therapeutics
Royal Marsden NHS Foundation Trust
Apollomics (Australia) Pty. Ltd.
Incyte Corporation
Incyte Corporation
University of Washington
Gustave Roussy, Cancer Campus, Grand Paris
Radboud University Medical Center